Medication Management of Antipsychotic-Induced Weight Gain in Children and Teens
The Carlat Child Psychiatry Report, Volume 13, Number 5&6, July 2022
https://www.thecarlatreport.com/newsletter-issue/ccpr13n5-6/
Issue Links: Learning Objectives | Editorial Information
Topics: body mass index BMI | GLP-1 Agonists | Metformin | Second Generation Antipsychotics (SGAs) | Topiramate | Weight gain
John C. Raiss, MD.
Assistant Clinical Professor of Child and Adolescent Psychiatry, UCLA David Geffen School of Medicine, Los Angeles, CA.
Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Once weight gain occurs with antipsychotic treatment in children and adolescents it is difficult to
reverse. How should you select and prescribe SGAs to prevent it? Which additional medications are
effective in preventing weight gain from SGAs? This clinical update gives you information to help
prevent this common and problematic side effect.
You can't view details of this content, please login or buy subscription here